Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › NEW ORLEANS › STONE CLINICAL LABORATORIES LLC

STONE CLINICAL LABORATORIES LLC

NPI: 1710433057 · NEW ORLEANS, LA 70113 · Clinical Medical Laboratory · NPI assigned 08/28/2016

$3.26M
Total Medicaid Paid
154,157
Total Claims
93,985
Beneficiaries
166
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBAUER, DANIELLE (DIRECTOR OF REVENUE CYCLE MANAGEMEN)
NPI Enumeration Date08/28/2016

Related Entities

Other providers sharing the same authorized official: BAUER, DANIELLE

ProviderCityStateTotal Paid
CHATTAHOOCHEE PHYSICIANS LABORATORY SERVICES, LLC ALPHARETTA GA $811K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 12,799 $64K
2019 27,225 $354K
2020 78,980 $2.16M
2021 10,473 $257K
2022 7,865 $260K
2023 4,811 $31K
2024 12,004 $134K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 66,127 23,427 $2.22M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 4,278 3,841 $143K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4,902 3,930 $122K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,681 4,604 $107K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5,662 2,507 $100K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,665 3,315 $69K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3,143 2,770 $49K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,868 2,572 $47K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3,429 2,560 $47K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7,848 3,345 $46K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 844 698 $42K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 660 526 $25K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 139 119 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 572 466 $14K
87631 914 868 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 907 826 $11K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 773 681 $9K
80053 Comprehensive metabolic panel 2,436 2,015 $9K
81226 50 43 $8K
80061 Lipid panel 1,844 1,673 $8K
87529 499 401 $7K
80074 416 363 $7K
86780 889 807 $7K
87481 823 633 $6K
80050 General health panel 333 315 $6K
81225 49 42 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,213 1,849 $6K
87486 1,013 944 $5K
87581 1,037 962 $5K
83036 Hemoglobin; glycosylated (A1C) 1,314 1,166 $4K
81231 50 43 $4K
84443 Thyroid stimulating hormone (TSH) 1,155 1,029 $4K
81230 50 43 $4K
87640 655 564 $4K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 235 232 $3K
81227 50 43 $3K
81328 50 43 $3K
83090 419 374 $3K
87541 351 310 $3K
84681 358 322 $3K
84439 772 697 $3K
86141 475 391 $3K
87088 849 808 $3K
87653 615 532 $3K
82607 416 381 $2K
84481 476 426 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 686 612 $2K
83525 430 374 $2K
82746 268 249 $2K
81401 31 27 $2K
86803 276 267 $2K
81355 50 43 $2K
81404 17 14 $2K
81241 49 42 $1K
82728 418 360 $1K
81350 18 15 $1K
87641 508 424 $1K
87511 208 139 $1K
81240 49 42 $1K
81291 50 43 $1K
81232 18 15 $1K
83876 149 133 $1K
87580 222 210 $1K
83698 268 237 $1K
81335 18 15 $978.95
87535 83 73 $973.10
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 89 84 $963.82
87081 174 170 $905.81
84466 237 219 $870.88
84550 543 486 $799.96
87086 Culture, bacterial; quantitative colony count, urine 486 466 $751.78
86706 187 186 $722.16
87563 242 180 $688.16
82977 233 217 $630.16
87500 216 191 $624.69
80048 Basic metabolic panel (calcium, ionized) 357 340 $538.80
82248 230 215 $459.08
80338 331 244 $445.43
83540 261 240 $444.99
87632 14 12 $436.12
87493 31 28 $388.27
84480 531 433 $355.62
84403 33 29 $346.76
87077 74 57 $340.60
82172 703 431 $272.71
84153 51 44 $259.26
87150 27 23 $219.88
83735 169 148 $218.74
87230 23 21 $212.07
82565 331 307 $202.62
80348 411 389 $202.36
80356 214 203 $189.96
83721 865 752 $188.10
87507 89 79 $175.05
80332 13 13 $141.73
84460 259 246 $138.83
81000 79 61 $136.08
87340 15 15 $108.24
84436 494 430 $105.58
84479 475 410 $93.50
86140 182 153 $93.15
83695 117 105 $91.66
87799 182 159 $87.97
80372 362 347 $80.42
80051 15 14 $75.50
86694 40 40 $57.92
82550 98 89 $47.30
87070 52 51 $37.35
83690 91 81 $37.13
80361 464 432 $34.22
80335 19 13 $34.19
80362 269 247 $17.00
83992 182 172 $14.63
82150 72 66 $12.52
85049 330 288 $12.50
80373 363 345 $10.35
80358 364 346 $8.69
85041 330 288 $8.60
85018 322 286 $6.76
85014 331 289 $6.76
82465 30 29 $3.90
80367 360 345 $0.00
80349 187 176 $0.00
80371 182 172 $0.00
84075 33 33 $0.00
80368 184 173 $0.00
84132 31 31 $0.00
80359 185 174 $0.00
80345 186 175 $0.00
82040 33 33 $0.00
82043 14 14 $0.00
80333 183 174 $0.00
80353 184 174 $0.00
84311 47 42 $0.00
80357 184 174 $0.00
82435 31 31 $0.00
84478 13 13 $0.00
83986 47 42 $0.00
81003 47 42 $0.00
82310 36 33 $0.00
80365 348 332 $0.00
80354 369 351 $0.00
80366 142 133 $0.00
84520 33 33 $0.00
84295 31 31 $0.00
80331 184 174 $0.00
82374 31 31 $0.00
80339 185 174 $0.00
80360 185 174 $0.00
80346 185 174 $0.00
84450 33 33 $0.00
80370 185 174 $0.00
84155 33 33 $0.00
80323 187 176 $0.00
83718 13 13 $0.00
82947 33 33 $0.00
81479 Unlisted molecular pathology procedure 147 27 $0.00
82570 47 42 $0.00
80355 142 133 $0.00
87538 23 17 $0.00
82247 33 33 $0.00
80321 187 175 $0.00
80364 185 175 $0.00
80325 186 175 $0.00
85270 13 13 $0.00
85004 28 26 $0.00